Dexxon Biotech
Biotech company developing and manufacturing pharmaceutical products and APIs.
Company Overview
Snapshot
Founded in March 2026, Dexxon Biotech operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on establishing its operations in the life sciences sector.
Business overview
Dexxon Biotech operates within the life sciences sector, specializing in the development and manufacture of pharmaceutical products and active pharmaceutical ingredients (APIs). The company's core offering is designed to support healthcare and life science supply chains through regulated production capabilities and product development. Dexxon Biotech primarily serves pharmaceutical companies and healthcare-related organizations that require reliable manufacturing and product supply.
Log in to access full profile ›Company Intelligence Q&A
- What is Dexxon Biotech's primary focus?
- Dexxon Biotech focuses on the development and manufacture of pharmaceutical products and active pharmaceutical ingredients (APIs) within the life sciences sector.
- When was Dexxon Biotech founded?
- Dexxon Biotech was founded in March 2026.
- What markets does Dexxon Biotech serve?
- Dexxon Biotech serves pharmaceutical companies and healthcare-related organizations that require reliable manufacturing and product supply.
- What is the current employee size of Dexxon Biotech?
- Dexxon Biotech currently has 1–10 employees.
- What is Dexxon Biotech's current funding stage?
- Dexxon Biotech is currently in the Pre-Funding stage, indicating it has not yet raised external capital.